Physician profile
Lawrence Shin
NPI 1467456137
$1,264.92
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $254 · 2021: $538 · 2022: $341.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $437.29 | 2021-2022 | |
| Medtronic USA, INC. | $261.41 | 2019-2020 | |
| Abbott Laboratories | $238.20 | 2019-2022 | |
| Medtronic, INC. | $208.01 | 2021-2022 | |
| Boston Scientific Corporation | $35.10 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.99 | 2022 | |
| Innovation Technologies INC | $17.91 | 2021 | |
| Kci USA, INC. | $16.26 | 2022 | |
| Amgen INC. | $15.56 | 2022 | |
| Zimmer Biomet Holdings, INC. | $12.19 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.